Home > Publications database > Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression. > print |
001 | 290623 | ||
005 | 20250819141944.0 | ||
024 | 7 | _ | |a 10.1016/j.devcel.2024.05.013 |2 doi |
024 | 7 | _ | |a pmid:38834071 |2 pmid |
024 | 7 | _ | |a 1534-5807 |2 ISSN |
024 | 7 | _ | |a 1878-1551 |2 ISSN |
024 | 7 | _ | |a altmetric:164152971 |2 altmetric |
037 | _ | _ | |a DKFZ-2024-01209 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Shiraishi, Ryo |b 0 |
245 | _ | _ | |a Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression. |
260 | _ | _ | |a New York, NY |c 2024 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1726063525_15964 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2024 Sep 9;59(17):2302-2319.e12 |
520 | _ | _ | |a Normal cells coordinate proliferation and differentiation by precise tuning of gene expression based on the dynamic shifts of the epigenome throughout the developmental timeline. Although non-mutational epigenetic reprogramming is an emerging hallmark of cancer, the epigenomic shifts that occur during the transition from normal to malignant cells remain elusive. Here, we capture the epigenomic changes that occur during tumorigenesis in a prototypic embryonal brain tumor, medulloblastoma. By comparing the epigenomes of the different stages of transforming cells in mice, we identify nuclear factor I family of transcription factors, known to be cell fate determinants in development, as oncogenic regulators in the epigenomes of precancerous and cancerous cells. Furthermore, genetic and pharmacological inhibition of NFIB validated a crucial role of this transcription factor by disrupting the cancer epigenome in medulloblastoma. Thus, this study exemplifies how epigenomic changes contribute to tumorigenesis via non-mutational mechanisms involving developmental transcription factors. |
536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a brain tumor |2 Other |
650 | _ | 7 | |a cerebellar granule cell |2 Other |
650 | _ | 7 | |a cerebellum |2 Other |
650 | _ | 7 | |a epigenome |2 Other |
650 | _ | 7 | |a medulloblastoma |2 Other |
650 | _ | 7 | |a mouse model |2 Other |
650 | _ | 7 | |a nuclear factor I |2 Other |
700 | 1 | _ | |a Cancila, Gabriele |b 1 |
700 | 1 | _ | |a Kumegawa, Kohei |b 2 |
700 | 1 | _ | |a Torrejon, Jacob |b 3 |
700 | 1 | _ | |a Basili, Irene |b 4 |
700 | 1 | _ | |a Bernardi, Flavia |b 5 |
700 | 1 | _ | |a Silva, Patricia Benites Goncalves da |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Wang, Wanchen |b 7 |
700 | 1 | _ | |a Chapman, Owen |b 8 |
700 | 1 | _ | |a Yang, Liying |b 9 |
700 | 1 | _ | |a Jami, Maki |b 10 |
700 | 1 | _ | |a Nishitani, Kayo |b 11 |
700 | 1 | _ | |a Arai, Yukimi |b 12 |
700 | 1 | _ | |a Xiao, Zhize |b 13 |
700 | 1 | _ | |a Yu, Hua |b 14 |
700 | 1 | _ | |a Lo Re, Valentina |b 15 |
700 | 1 | _ | |a Marsaud, Véronique |b 16 |
700 | 1 | _ | |a Talbot, Julie |b 17 |
700 | 1 | _ | |a Lombard, Bérangère |b 18 |
700 | 1 | _ | |a Loew, Damarys |b 19 |
700 | 1 | _ | |a Jingu, Maho |b 20 |
700 | 1 | _ | |a Okonechnikov, Konstantin |0 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110 |b 21 |u dkfz |
700 | 1 | _ | |a Sone, Masaki |b 22 |
700 | 1 | _ | |a Motohashi, Norio |b 23 |
700 | 1 | _ | |a Aoki, Yoshitsugu |b 24 |
700 | 1 | _ | |a Pfister, Stefan M |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 25 |u dkfz |
700 | 1 | _ | |a Chavez, Lukas |b 26 |
700 | 1 | _ | |a Hoshino, Mikio |b 27 |
700 | 1 | _ | |a Maruyama, Reo |b 28 |
700 | 1 | _ | |a Ayrault, Olivier |b 29 |
700 | 1 | _ | |a Kawauchi, Daisuke |b 30 |
773 | _ | _ | |a 10.1016/j.devcel.2024.05.013 |g p. S1534580724003307 |0 PERI:(DE-600)2053870-4 |n 17 |p 2302-2319.e12 |t Developmental cell |v 59 |y 2024 |x 1534-5807 |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/290623/files/1-s2.0-S1534580724003307-main.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/290623/files/1-s2.0-S1534580724003307-main.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:290623 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 21 |6 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 25 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-24 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-24 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b DEV CELL : 2022 |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-24 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-24 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b DEV CELL : 2022 |d 2023-10-24 |
920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B062-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|